The global compounding pharmacies market size is projected at USD 15.4 Bn in 2026.
The compounding pharmacies market is expected to grow at a 5% CAGR through 2033.
The compounding pharmacies market growth is driven by rising personalized medicine demand, persistent drug shortages, and aging populations with chronic diseases.
North America is the dominant region for the compounding pharmacies market.
Walgreens Co., Fagron, B. Braun, Fresenius Kabi, and Clinigen Group are some leading industry players in the compounding pharmacies market.